Matthew Streetly
- Hematology top 1%
- Molecular Biology
- Oncology top 5%
- Immunology
- Genetics top 10%
- Co-authors
- Stephen ScheyMajid KazmiPaul FieldsJ. Blake BartlettIan ClarkeRobert KnightAngus DalgleishSteve Schey
- Topics
- Multiple Myeloma Research and Treatments (38 papers)Protein Degradation and Inhibitors (17 papers)Peptidase Inhibition and Analysis (14 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Matthew Streetly
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 69
- Hematology 799
- Molecular Biology 586
- Oncology 523
- Immunology 213
- Genetics 137
Countries citing papers authored by Matthew Streetly
This map shows the geographic impact of Matthew Streetly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Streetly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Streetly more than expected).
Fields of papers citing papers by Matthew Streetly
This network shows the impact of papers produced by Matthew Streetly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Streetly. The network helps show where Matthew Streetly may publish in the future.
Co-authorship network of co-authors of Matthew Streetly
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Streetly. A scholar is included among the top collaborators of Matthew Streetly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Streetly. Matthew Streetly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | 7 | |
| 4 | 56 | |
| 5 | 14 | |
| 6 | 6 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 27 | |
| 10 | 5 | |
| 11 | 26 | |
| 12 | 35 | |
| 13 | 0 | |
| 14 | 94 | |
| 15 | 35 | |
| 16 | 30 | |
| 17 | 87 | |
| 18 | 8 | |
| 19 | 29 | |
| 20 | Changes in neutrophil phenotype following the administration of CC-4047 (Actimid) to patients with multiple myeloma. | 1 |
About Matthew Streetly
Matthew Streetly is a scholar working on Hematology, Oncology and Genetics, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (17 papers) and Peptidase Inhibition and Analysis (14 papers). The work is most often cited by research in Hematology (799 citations), Oncology (523 citations) and Genetics (137 citations). Matthew Streetly has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Stephen Schey, Majid Kazmi, Paul Fields, J. Blake Bartlett, Ian Clarke, Robert Knight, Angus Dalgleish, Steve Schey, Jerome B. Zeldis and Finbarr E. Cotter. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.